I've been doing meta-analyses on medication use and/or exposure during pregnancy for a while. Because ethical barriers exist regarding RCTs, the best evidence in this field usually comes from prospective cohort and case-control studies both of which may have different types of biases.  

My question is; would you combine the case-control and cohort data in the same meta-analysis or would you prefer to do them seperately? Is combining both in the same meta-analysis definetely an unacceptable thing or is it a choice?

I'd very much appreciate your suggestions.

More Yusuf Cem Kaplan's questions See All
Similar questions and discussions